2009

• Liu, G., Nagarajah, R., Banati, R., Bennett, M. Glutamate induces directed chemotaxis of microglia. European Journal of Neuroscience. 2009; 29:1108-1118. [Abstract]
• Banati, R., Hickie, I. Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Medical Journal of Australia. 2009; 190:S26-S32. [Abstract]
• Kassiou, M., Banati, R., Holsinger, R., Meikle, S. Challenges in molecular imaging of Parkinson's disease: A brief overview. Brain research bulletin. 2009; 78:105-8. [Abstract]
• Hickie, I., Banati, R., Stewart, C., Lloyd, A. Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?. The Medical Journal of Australia. 2009; 190:S17-S21. [Abstract]

2008

• Rybovic, M., Banati, R., Cox, J. Radiation therapy treatment verification imaging in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology. 2008; 52:183-190. [Abstract]

2007

• Naidoo-Variawa, S., Hey-Cunningham, A., Lehnert, W., Kench, P., Kassiou, M., Banati, R., Meikle, S. High-resolution imaging of the large non-human primate brain using microPET: a feasibility study. Physics in medicine and biology. 2007; 52:6627-38. [Abstract]
• Liu, X., Banister, S., Christie, M., Banati, R., Meikle, S., Coster, M., Kassiou, M. Trishomocubanes: Novel sigma ligands modulate cocaine-induced behavioural effects. European journal of pharmacology. 2007; 555:37-42. [Abstract]
• Kassiou, M., Meikle, S., Cagnin, A., Banati, R. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics. 2007; 4:443-452. [Abstract]

2006

• Lehnert, W., Meikle, S., Siegel, S., Newport, D., Banati, R., Rosenfeld, A. Evaluation of transmission methodology and attenuation correction for the microPET Focus 220 animal scanner. Physics in medicine and biology. 2006; 51:4003-16. [Abstract]
• Cagnin, A., Taylor-Robinson, S., Forton, D., Banati, R. In vivo imaging of cerebral "peripheral benzodiazepine binding sites'' in patients with hepatic encephalopathy. Gut. 2006; 55:547-553. [Abstract]
• Cagnin, A., Taylor-Robinson, S., Forton, D., Banati, R. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut. 2006; 55:547-53. [Abstract]
• Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I., Naylor, A., Bountra, C., Banati, R., Anand, P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. Bmc Neurology. 2006; 6:0. [Abstract]
• Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R., Brooks, D. In vivo imaging of microglial activation with C-11 (R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiology of Disease. 2006; 21:404-412. [Abstract]
• Cagnin, A., Kassiou, M., Meikle, S., Banati, R. In vivo evidence for microglial activation in neuro degenerative dementia. Acta Neurologica Scandinavica. 2006; 114:107-114. [Abstract]

2005

• Meikle, S., Kench, P., Kassiou, M., Banati, R. Small animal SPECT and its place in the matrix of molecular imaging technologies. Physics in medicine and biology. 2005; 50:R45-61. [Abstract]
• Wirenfeldt, M., Ladeby, R., Dalmau, I., Banati, R., Finsen, B. [Microglia--biology and relevance to disease]. Ugeskrift for laeger. 2005; 167:3025-30. [Abstract]
• Kassiou, M., Meikle, S., Banati, R. Ligands for peripheral benzodiazepine binding sites in glial cells. Brain research. Brain research reviews. 2005; 48:207-10. [Abstract]
• Gulyás, B., Halldin, C., Vas, A., Banati, R., Shchukin, E., Finnema, S., Tarkainen, J., Tihanyi, K., Szilágyi, G., Farde, L. [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. Journal of the neurological sciences. 2005; 229-230:219-23. [Abstract]
• Gerhard, A., Schwarz, J., Myers, R., Wise, R., Banati, R. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. NeuroImage. 2005; 24:591-5. [Abstract]